Pfizer’s stock drops after it lowers its revenue forecast
The drugmaker revised its revenue guidance for 2025, saying it now expects $62 billion in revenue for the year.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
